Publications in collaboration with researchers from Hospital Universitario Puerta de Hierro (2)

2022

  1. Risankizumab in psoriasis: prior biologics failure does not impact on short-term effectiveness

    Expert Opinion on Biological Therapy

2020

  1. A retrospective, observational multicenter study of 141 patients treated with ustekinumab 90 mg

    Dermatologic Therapy, Vol. 33, Núm. 4